A Multicenter Phase 2 study of Hypofractionated Stereostatic Boost in Intermediate Risk Prostate Carcinoma: A 5-Year Analysis of the CKNO-PRO Trial - Archive ouverte HAL Access content directly
Journal Articles International Journal of Radiation Oncology, Biology, Physics Year : 2020

A Multicenter Phase 2 study of Hypofractionated Stereostatic Boost in Intermediate Risk Prostate Carcinoma: A 5-Year Analysis of the CKNO-PRO Trial

Fichier principal
Vignette du fichier
S0360301619338635.pdf (361.09 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03488754 , version 1 (21-07-2022)

Licence

Attribution - NonCommercial

Identifiers

Cite

David Pasquier, Didier Peiffert, Philippe Nickers, Philippe Maingon, Pascal Pommier, et al.. A Multicenter Phase 2 study of Hypofractionated Stereostatic Boost in Intermediate Risk Prostate Carcinoma: A 5-Year Analysis of the CKNO-PRO Trial. International Journal of Radiation Oncology, Biology, Physics, 2020, 106, pp.116 - 123. ⟨10.1016/j.ijrobp.2019.09.039⟩. ⟨hal-03488754⟩
19 View
33 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More